About Biologics

Biologics Overview

Want to know everything you can about biologics? Learn about biologic response modifiers and other prescription medications. Read More >>

Two Biologic Drugs Go Head-to-Head in Study

When given as the sole treatment for rheumatoid arthritis, Actemra outperformed Humira at reducing painful, swollen joints and other signs of RA. Read More >>

RA Drug Delivery Changes Offer Convenience, Easier Use

FDA has approved new delivery methods for methotrexate and tocilizumab, which provide more convenient treatment options for RA patients. Read More >>

Short-Term “Drug Holidays” are Safe for Orencia

Taking a break from the biologic medication abatacept, or Orencia, will not affect your long-term response to therapy, according to a new study. Read More >>

When an Anti-TNF Fails for Rheumatoid Arthritis, What’s Next?

New study shows rheumatoid arthritis patients who don’t respond to anti-TNFs may respond to the biologic Rituxan instead of a second anti-TNF. Read More >>

FDA Approves New Drug for Rheumatoid Arthritis

The Food and Drug Administration, FDA, has approved a new oral medication called tofacitinib, or Xeljanz, for rheumatoid arthritis. Find out what this new RA treatment means for you. Read More >>

Precautions to Take Before Starting Biologics

To reduce the risk of harmful infections, take these measures before starting biologics. Read More >>

Deconstructing Biologics

Discover how biologic drugs work when treating rheumatoid arthritis. Read More >>